Latest / US News Today | 2 Min News | The Daily News Now!
FDA Approves First PCSK9 Pill for Cholesterol | US News
FDA just approved Lipfendra, the first daily pill targeting PCSK9 to slash bad cholesterol—offering a cheaper, no-shot alternative to pricey injectables. At $315/month, it’s a game-changer for adults on max statins, slashing LDL by 56-59% in trials. Cardiologists are thrilled: this could make cholesterol control as routine as a daily statin, empowering primary care doctors and helping meet new heart attack/stroke prevention goals. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.